105 related articles for article (PubMed ID: 8771099)
1. The management of early ovarian cancer.
Schilder RJ; Boente MP; Corn BW; Lanciano RM; Young RC; Ozols RF
Oncology (Williston Park); 1995 Feb; 9(2):171-82; discussion 185-7. PubMed ID: 8771099
[TBL] [Abstract][Full Text] [Related]
2. Management of early-stage ovarian cancer.
Schilder RJ; Young RC
Hematol Oncol Clin North Am; 1992 Aug; 6(4):867-77. PubMed ID: 1500390
[TBL] [Abstract][Full Text] [Related]
3. The treatment of early stage ovarian cancer.
Young RC
Semin Oncol; 1995 Oct; 22(5 Suppl 12):76-9. PubMed ID: 7481865
[TBL] [Abstract][Full Text] [Related]
4. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
5. Management of early ovarian cancer.
Young RC; Pecorelli S
Semin Oncol; 1998 Jun; 25(3):335-9. PubMed ID: 9633845
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials.
Young RC; Walton LA; Ellenberg SS; Homesley HD; Wilbanks GD; Decker DG; Miller A; Park R; Major F
N Engl J Med; 1990 Apr; 322(15):1021-7. PubMed ID: 2181310
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II].
Sevelda P; Gitsch E; Dittrich C; Haider F; Czerwenka K; Schemper M; Salzer H
Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):179-85. PubMed ID: 3556307
[TBL] [Abstract][Full Text] [Related]
8. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
9. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
10. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
11. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
12. Management of early ovarian cancer.
Sonoda Y
Oncology (Williston Park); 2004 Mar; 18(3):343-56; discussion 358, 361-2. PubMed ID: 15065703
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of ovarian cancer.
Ozols RF
Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699
[TBL] [Abstract][Full Text] [Related]
14. Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer.
Ceelen WP; Van Nieuwenhove Y; Van Belle S; Denys H; Pattyn P
Ann Surg Oncol; 2012 Jul; 19(7):2352-9. PubMed ID: 20039210
[TBL] [Abstract][Full Text] [Related]
15. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
16. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy consisting of cisplatin, doxorubicin and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.
De Pree N; Wils J
Anticancer Res; 1989; 9(6):1873-5. PubMed ID: 2697191
[TBL] [Abstract][Full Text] [Related]
18. Current aspects of adjuvant therapy of early stage ovarian cancer.
McGuire WP
Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]